Dyne Therapeutics

$16.70
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.05 (-0.30%) Today
$0.00 (0.00%) As of 9:14 PM UTC after-hours

Why Robinhood?

You can buy or sell DYN and other stocks, options, and ETFs commission-free!

About DYN

Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph.

CEO
Joshua T. Brumm
Employees
47
Headquarters
Waltham, Massachusetts
Founded
2017
Market Cap
843.95M
Price-Earnings Ratio
Dividend Yield
Average Volume
254.75K
High Today
$16.85
Low Today
$16.16
Open Price
$16.63
Volume
222.91K
52 Week High
$32.32
52 Week Low
$13.50

DYN Earnings

-$2.01
-$1.34
-$0.67
$0.00
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected May 6, Pre-Market

You May Also Like

EGO
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure